Dividend Channel
Market News Video Dividend Detective The Warren Buffetts Next Door Stock message boards
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Notable Tuesday Option Activity: UPS, BEAT, KNX
Tuesday, July 24, 3:16 PM ET, by Market News Video Staff

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume ...

BioTelemetry Reaches Analyst Target Price
Friday, July 27, 8:41 AM ET, by Market News Video Staff

In recent trading, shares of BioTelemetry Inc (BEAT) have crossed above the average analyst 12-month ...

First Week of November 16th Options Trading For Varex Imaging (VREX)
Friday, July 27, 10:58 AM ET, by Market News Video Staff

Investors in Varex Imaging Corp (VREX) saw new options become available this week, for the ...

December 2019 Options Now Available For BioTelemetry (BEAT)
Monday, July 30, 10:53 AM ET, by Market News Video Staff

Investors in BioTelemetry Inc (BEAT) saw new options begin trading today, for the December 2019 ...

Notable Wednesday Option Activity: DXCM, BEAT, CLH
Wednesday, August 1, 3:22 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Look Under The Hood: IHI Has 13% Upside

By Dividend Channel Staff, Thursday, October 11, 7:45 AM ET
Play Video: The Importance of ETFs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares U.S. Medical Devices ETF (NYSE:IHI), we found that the implied analyst target price for the ETF based upon its underlying holdings is $235.22 per unit.

With IHI trading at a recent price near $208.84 per unit, that means that analysts see 12.63% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of IHI's underlying holdings with notable upside to their analyst target prices are TransEnterix Inc (AMEX:TRXC), BioTelemetry Inc (NASDAQ:BEAT), and Varex Imaging Corp (NASDAQ:VREX). Although TRXC has traded at a recent price of $4.51/share, the average analyst target is 38.58% higher at $6.25/share. Similarly, BEAT has 26.57% upside from the recent share price of $52.41 if the average analyst target price of $66.33/share is reached, and analysts on average are expecting VREX to reach a target price of $31.50/share, which is 24.75% above the recent price of $25.25. Below is a twelve month price history chart comparing the stock performance of TRXC, BEAT, and VREX:

TRXC, BEAT, and VREX Relative Performance Chart

Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
iShares U.S. Medical Devices ETF IHI $208.84 $235.22 12.63%
TransEnterix Inc TRXC $4.51 $6.25 38.58%
BioTelemetry Inc BEAT $52.41 $66.33 26.57%
Varex Imaging Corp VREX $25.25 $31.50 24.75%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on TRXC FREE
Get the latest Zacks research report on BEAT FREE
Get the latest Zacks research report on VREX FREE

This Article's Word Cloud:   Analyst   BEAT   Below   BioTelemetry   Corp   Devices   ETFs   FREEGet   Imaging   Medical   TRXC   Target   TransEnterix   Upside   VREX   Varex   With   Zacks   about   above   analyst   analysts   average   background   based   border   bottom   color   data   font   from   have   hctblstyle   holdings   iShares   implied   latest   month   padding   price   recent   report   research   share   target   targets   that   trading   underlying   upside

Look Under The Hood: IHI Has 13% Upside | www.DividendChannel.com | Copyright © 2010 - 2018, All Rights Reserved

Nothing in Dividend Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and dividend videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.